Position in DHR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,099,292
+$2,354,084 QoQ
Shares Held
26,895
+124.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 5.904443205056702.ToString("F0")%
Shared 0.ToString("F0")%
None 94.0955567949433.ToString("F0")%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Voleon Capital Management LP holds $27,049,861 across 9 Diagnostics & Research names. DHR ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRAL |
GRAIL, Inc.
|
144,955 | $7,491,274 | |
| 2 | MTD |
Mettler Toledo International Inc/
|
4,510 | $5,688,012 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
26,895 | $5,099,292 | |
| 4 | GH |
Guardant Health, Inc.
|
55,000 | $5,080,350 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,292 | $1,287,851 | |
| 6 | NTRA |
Natera, Inc.
|
5,515 | $1,102,944 | |
| 7 | MYGN |
Myriad Genetics Inc
|
137,241 | $617,584 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
747 | $367,172 |
All Filings in DHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,099,292 | 26,895 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,745,208 | 11,992 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,698,704 | 53,963 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,156,624 | 41,291 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||